Student Well-Being

Fauci’s Latest on Vaccines for Young Kids: Not Likely This Year

By Arianna Prothero — February 22, 2021 2 min read
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, listens as President Joe Biden visits the Viral Pathogenesis Laboratory at the National Institutes of Health on Feb. 11, 2021, in Bethesda, Md.

A COVID-19 vaccine probably won’t be ready for young schoolchildren until 2022, the country’s top infectious disease expert has said.

In a recent White House press briefing, Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, walked back his comments from a ProPublica interview, published Feb. 11, in which he said he was hopeful that children as young as 1st grade would be able to start getting vaccinated in the fall.

Other experts in infectious disease and pediatrics had said that timeline was overly optimistic. In particular, the American Academy of Pediatrics has raised concerns that there has not been enough urgency among vaccine developers in getting trials done for children under 16.

In a White House press briefing Friday, Fauci said it was unlikely there would be enough data from vaccine trials to approve a COVID-19 vaccine for elementary-age children until the first quarter of next year.

See Also

Vaccine in a bottle with a syringe.
iStock/Getty
Student Well-Being Explainer COVID-19 Vaccines and Schools: Your Questions Answered
Education Week Staff, January 5, 2021
7 min read

The new prediction is more in line with what other health experts have been saying.

However, Fauci said it is quite possible that a vaccine could be ready for approval for older adolescents in the fall, although not necessarily at the start of the school year.

“It is highly likely that sometime in the fall we will have data that will give us the capability of saying the safety and comparable efficacy in children 12 to 17, 18 years old,” he said. “Again, the final decisions we always leave to the FDA. I’m trying to give you a road map of what likely will happen.”

Other experts have told EdWeek that they think a vaccine could be approved for middle and high school students in the fall, although they caution that just because a vaccine is approved doesn’t mean it will be widely available.

Currently, some teenagers can get the two vaccines given emergency authorization so far by the Food and Drug Administration. The vaccine developed by U.S. drugmaker Pfizer and the German company BioNTech was approved for ages 16 and up. The vaccine created by U.S. biotechnology company Moderna has been approved for ages 18 and up.

However, because higher-risk groups such as the elderly, the immunocompromised, and frontline health-care workers are being prioritized in the initial phases of states’ rollouts, it’s unlikely that 16- to 19-year-olds will be getting widely vaccinated any time soon, unless they are immunocompromised.

Vaccine trials in children are done first in older age brackets, eventually working down to infants. Pfizer and Moderna are currently studying their vaccines in children 12 and older. Pfizer has said it plans to start trials for children ages 5 to 11 in the first half of 2021.

Developing a COVID-19 vaccine for children is more complicated than simply lowering the dosage because children’s immune systems are different from adults. The vaccines that have been approved in the United States do not use a live virus, but rather genetic material that triggers an immune response in the body. Children’s immune systems operate differently than those of adults.

Related Tags:

Events

This content is provided by our sponsor. It is not written by and does not necessarily reflect the views of Education Week's editorial staff.
Sponsor
Student Well-Being Webinar
How Principals Can Support Student Well-Being During COVID
Join this webinar for tips on how to support and prioritize student health and wellbeing during COVID.
Content provided by Unruly Studios
This content is provided by our sponsor. It is not written by and does not necessarily reflect the views of Education Week's editorial staff.
Sponsor
Professional Development Webinar
Building Leadership Excellence Through Instructional Coaching
Join this webinar for a discussion on instructional coaching and ways you can link your implement or build on your program.
Content provided by Whetstone Education/SchoolMint
Teaching Webinar Tips for Better Hybrid Learning: Ask the Experts What Works
Register and ask your questions about hybrid learning to our expert panel.

EdWeek Top School Jobs

President and CEO
Alexandria, Virginia
National Association of State Boards of Education
CCLC Program Site Director
Thornton, CO, US
Adams 12 Five Star Schools
CCLC Program Site Director
Thornton, CO, US
Adams 12 Five Star Schools
Marketing Coordinator
Portland, OR, US
Northwest Evaluation Association

Read Next

This content is provided by our sponsor. It is not written by and does not necessarily reflect the views of Education Week's editorial staff.
Sponsor
Student Well-Being Whitepaper
Guide: Supporting K-12 Student Success
Download this guide to create impactful family and community partnerships.
Content provided by Salesforce
Student Well-Being What the Research Says 6 Feet or 3 Feet: How Far Apart Do Students Need to Be?
The new CDC guidelines call for spacing students 6 feet apart to prevent the spread of COVID-19. But schools elsewhere use a 3-foot buffer.
5 min read
Image of a classroom.
miljko/E+/Getty
Student Well-Being Opinion New Research Explains Why Confessions Are Convincing
Admitting mistakes makes you come across as knowledgeable—and it’s a good way to model intellectual humility.
Sam Maglio
2 min read
Images shows a stylized artistic landscape with soothing colors.
Getty
Student Well-Being Spotlight Spotlight on Forging Student Connections & Growth Mindsets
In this Spotlight, discover ways to foster a growth mindset to re-connect and engage with students.